| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 09/18/2008 | US20080226646 Use of biomolecular targets in the treatment and visualization of tumors |
| 09/17/2008 | EP1970060A2 Use of C-(2-Phenyl-cyclohexyl)-methylamine compounds for fibromyalgia therapy |
| 09/17/2008 | EP1969368A2 Potentiation of apoptosis by monoclonal antibodies |
| 09/17/2008 | EP1969125A2 Micrornas that regulate muscle cell proliferation and differentiation |
| 09/17/2008 | EP1409477B1 Piperidine derivatives as nmda receptor antagonists |
| 09/17/2008 | EP1284999B1 Repair of nerve damage |
| 09/17/2008 | CN100418533C Pharmaceutical combinations of cox-2 inhibitors and opiates |
| 09/16/2008 | US7425610 Expression vector comprising nucleotide sequences coding novel receptor protein for use in prevention and treatment of cell proliferative and autoimmune disorders |
| 09/16/2008 | US7425566 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 09/16/2008 | US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 09/16/2008 | US7425331 Protein A methods of use |
| 09/16/2008 | CA2376193C Therapeutic agent comprising a botulinum neurotoxin |
| 09/12/2008 | WO2008108322A2 Composition and method for protecting mitochondria |
| 09/11/2008 | US20080221186 4-(substituted cycloalkylmethyl) Imidazole-2-Thiones, 4-(substituted cycloalkenylmethyl) Imidazole-2-Thiones, 4-(substituted cycloalkylmethyl) Imidazol-2-Ones and 4-(substituted cycloalkenylmethyl) Imidazole-2-Ones and related compounds |
| 09/11/2008 | US20080221111 Combination of a Pd4 Inhibitor and a Tetrahydrobiopterin Derivative |
| 09/11/2008 | US20080221019 Treatment of Inclusion Body Myositis |
| 09/11/2008 | US20080221012 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types |
| 09/11/2008 | US20080220057 Therapeutic compounds and methods of use |
| 09/11/2008 | US20080220020 Transdermal Botulinum Toxin Compositions |
| 09/10/2008 | EP1965830A1 Use of alkaline phosphatase to maintain healthy tissue mass in mammals |
| 09/10/2008 | EP1965669A1 Use of soluble dietary fibres against muscle wasting |
| 09/10/2008 | EP1427708B1 Amino-phthalazinone derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 09/10/2008 | EP1349861B1 THIENO(3,2-d)PYRIMIDINES AND FURANO(3,2-d)PYRIMIDINES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 09/10/2008 | EP1159006B1 Water-soluble compositions of bioactive lipophilic compounds |
| 09/10/2008 | CN101260046A Method for refining cyclobenzaprine hydrochloride |
| 09/10/2008 | CN101259209A Chinese medicine preparation for treating asthenia |
| 09/10/2008 | CN100417659C Nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 09/09/2008 | US7423055 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
| 09/09/2008 | US7423049 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 09/09/2008 | US7423047 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 09/09/2008 | US7422877 Activatable recombinant neurotoxins |
| 09/09/2008 | CA2323086C Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/04/2008 | WO2008105526A1 Macrocyclic compound |
| 09/04/2008 | WO2008105392A1 3-amino-2-indolylbutyrolactam derivative, process for production of the same, and pharmaceutical agent comprising the same as active ingredient |
| 09/04/2008 | US20080214781 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 09/04/2008 | US20080214660 Compounds and Methods for the Inhibition of the Expression of VCAM-1 |
| 09/04/2008 | US20080214629 Administering a dosage form of 6-20 mg of tizanidine; plasma drug concentration substantially ascends over a period of 8 hours following administration |
| 09/04/2008 | US20080214623 N-(2,2-Dimethylpropyl)-6-{3-fluoro-5-[(3-isoxazolylamino)carbonyl]-2-methylphenyl}-3-pyridinecarboxamide; inhibitors of p38 kinase |
| 09/04/2008 | US20080213776 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same |
| 09/04/2008 | US20080213339 Pharmaceutical Composition Containing Indometacin and/or Acemetacin |
| 09/04/2008 | US20080213315 free of non-300 kD botulinum toxin type A complexes |
| 09/04/2008 | US20080213312 Botulinum toxin treatments |
| 09/04/2008 | US20080213234 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 09/04/2008 | US20080213221 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 09/04/2008 | US20080213182 Administering a recombinant adeno-associated virus (rAAV) containing a transgene that encodes a protein MBNL1, MBNL2, or MBNL3 |
| 09/04/2008 | CA2679126A1 Macrocyclic compound |
| 09/03/2008 | EP1465626B1 Pharmaceutical compositions (kit) comprising dihydropyridinone compounds and an immunoregulatory (or an antiinflammatory) agent and their uses |
| 09/03/2008 | EP1389094B1 Delivery of sedative-hypnotics trough an inhalation route |
| 09/03/2008 | EP1343781B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/03/2008 | EP1339398B1 Treatment of motor fluctuations with 5-hydroxytryptamine 1a receptor activity enhancing compounds |
| 09/03/2008 | CN101254185A Use of cyclic enol ether terpenoid for producing promotive neurocyte proliferate and differentiation medicament |
| 09/03/2008 | CN101254176A Freeze-dried powder needle preparations taking dantrolene sodium as activity component and preparation technique thereof |
| 09/03/2008 | CN100415747C Phosphodiesterase 4 inhibitors |
| 09/03/2008 | CN100415744C 2-arylamino-pyrimidines for the treatment of GSK3-related disorders |
| 09/03/2008 | CN100415724C Pyrimidine derivatives |
| 09/03/2008 | CN100415718C CASPASE inhibitors and use thereof |
| 09/03/2008 | CN100415246C Compositions for preparing external carbon dioxide agents |
| 09/02/2008 | US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 09/02/2008 | US7419999 Gamma lactams as prostaglandin agonists and use thereof |
| 09/02/2008 | US7419994 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compounds |
| 09/02/2008 | US7419676 Activatable recombinant neurotoxins |
| 09/02/2008 | US7419670 Method of treating arthritis with SERP-1 and an immunosuppressant |
| 08/28/2008 | WO2008102749A1 Heterocyclic compound |
| 08/28/2008 | WO2008102372A1 A composition derived from fenugreek for improving physiology |
| 08/28/2008 | WO2008101824A1 Imidazo[1',5':1,6] pyrido[3,4-b]indoles derivatives and therapeutical use thereof |
| 08/28/2008 | WO2008101313A1 Preparation of amino acid-fatty acid amides |
| 08/28/2008 | WO2007042271A8 Nutraceutical composition for the treatment of muscle wasting |
| 08/28/2008 | US20080209581 Induction of exon skipping in eukaryotic cells |
| 08/28/2008 | US20080207642 Respiratory system disorders; asthma; chronic obstructive pulmonary diseases; autoimmune diseases; antiproliferative agents; anticancer agents |
| 08/28/2008 | US20080207576 Substituted sapogenins and their use |
| 08/28/2008 | US20080207550 Immunomodulatory polynucleotides and methods of using the same |
| 08/28/2008 | US20080207489 Use of CCN5 for treatment of smooth muscle proliferation disorders |
| 08/28/2008 | US20080206267 Inactivation Of Genes Of The Mep Pathway |
| 08/28/2008 | US20080206224 Muscle contraction treatment utilizing botulinum toxin |
| 08/28/2008 | US20080206223 Treatment of pompe's disease |
| 08/28/2008 | US20080206208 Adipose tissue culture use in treatment and prevention of cardiomyopathies; tissue engineering; regenerative medicine |
| 08/27/2008 | EP1961748A2 2-hydroxy-3-heteroarylindole derivatives as GSK3 inhibitors |
| 08/27/2008 | EP1960431A1 Use of effector-function-deficient antibodies for treatment of auto-immune diseases |
| 08/27/2008 | EP1337560B1 Truncated cd200 |
| 08/27/2008 | CN100413860C Piperidine derivative as NMDA receptor antagonist |
| 08/27/2008 | CN100413512C Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass |
| 08/26/2008 | US7417110 Biocompatability; polyphosphoester/polyphosphoramidate linkages; improved gene delivery into muscles; DNA vaccines |
| 08/26/2008 | US7417029 Using an interleukin-1 beta converting enzyme inhibitor pro-drug to treat apoptosis-, interferon-gamma inducing factor or interferon-gamma inducing diseases; antiinflammatory and -proliferative agents; autoimmune/degenerative disesesdiseases |
| 08/26/2008 | US7416885 Proliferation factor is obtained from the UCHT1 rat thyroid cell line, or a fragment, analogue or derivateve |
| 08/26/2008 | CA2432129C Pyrazole compounds useful as protein kinase inhibitors |
| 08/21/2008 | WO2007100695A3 Metabolic regulators and uses thereof |
| 08/21/2008 | US20080200547 Highly Purified Ethyl EPA and Other EPA Derivatives |
| 08/21/2008 | US20080200484 Pharmaceutical Compositions Comprising A Multifunctional Phosphodiesterase Inhibitor and An Adenosine Uptake Inhibitor |
| 08/21/2008 | US20080200407 Suppress the immunoreactivity of a CpG motif and preventing and treating immune-mediated diseases such as arthritis |
| 08/21/2008 | US20080200398 Compounds For Enzyme Inhibition |
| 08/21/2008 | US20080200373 Multi-Component Biological Transport Systems |
| 08/21/2008 | US20080199865 Using allelic variation in interleukin-1RN variable number of tandem repeats as diagnostic/prognostic indicator of decrease cell division and aging characteristics |
| 08/21/2008 | DE60037007T2 Angereicherte zentralnervensystem-zellpopulationen Enriched cns-cell populations |
| 08/20/2008 | EP1958503A2 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 08/20/2008 | EP1957082A1 Use of high-dose oxazaphosphorine drugs for treating immune disorders |
| 08/20/2008 | EP1451202B1 Aryl fused azapolycyclic compounds |
| 08/20/2008 | EP1289993B9 Caspase inhibitors and uses thereof |
| 08/20/2008 | CN101244074A Uses of epimedium brevicornum flavone and its active ingredient in preparing medicaments for accelerating neurocyte proliferation and differentiation function |
| 08/20/2008 | CN100412073C Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 08/20/2008 | CN100411616C Methocarbamol dispersion tablet |